XNK Therapeutics logo
Svenska
Svenska
  • About XNK Therapeutics
    About XNK Therapeutics
    Close
    • Organisation
      Management
      Board of directors
      Advisors
      Collaborations and partners
    • Career
      Vacant positions
  • Our Science
    Our Science
    Close
    • Introduction to Cell Therapy
      The XNK Technology Platform
      Benefits
      Potential Indications
      Protection of intellectual property
    • Pipeline
      Clinical Trials
      ACP-001
      ISA-HC-NK
    • Research & Development
  • Investors
    Investors
    Close
    • General meetings
  • Media
    Media
    Close
    • Press releases
    • Subscribe
    • Presentations
  • Contact
  • About XNK Therapeutics
    • Organization
      • Management
      • Board of directors
      • Advisors
    • Collaborations and partners
    • Career
      • Vacant positions
  • Our Science
    • Introduction to Cell Therapy
    • The XNK Technology Platform
      • Benefits
      • Potential Indications
      • Protection of intellectual property
    • Pipeline
    • Clinical Trials
      • ACP-001
      • ISA-HC-NK
    • Research & Development
  • Investors
    • General meetings
  • Media
    • Press releases
    • Subscribe
    • Presentations
  • Contact

Subscribe

Subscribe via e-mail

Read more about our protection of your personal data.
  • Media
    • Press releases
    • Subscribe
    • Presentations

Subscribe

Read more about our protection of your personal data.

XNK Therapeutics AB

Hälsovägen 7, Novum
141 57 Huddinge
SWEDEN

Email: info@xnktherapeutics.com

© 2022 XNK Therapeutics

  • Cookies
  • Privacy Policy
  • Integritetspolicy avseende aktieägare